Compugen Ltd (CGEN)

[surf1944]

7:56AM Compugen discloses focused target discovery program for antibody-drug conjugate cancer therapy (CGEN) : Co disclosed the initiation of its second focused discovery program, aimed at identification of novel targets for antibody-drug conjugate cancer therapy focusing on clinical situations with poor survival rates and/or recurrent cancers. This second program follows Compugen's successful initial focused discovery program for novel immune checkpoint proteins, a number of which have been incorporated in the Company's Pipeline Program as Fc fusion protein drugs for immunology and/or as therapeutic targets for monoclonal antibody drugs for cancer immunotherapy.

Second program follows initial program that resulted in discovery of multiple novel immune checkpoint molecules and establishment of Pipeline Program.
Initial discoveries from new program anticipated before year-end